Reckitt Extends Children's Mucinex Line In Widening Consumer Strategy
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser announces a line extension for its Mucinex franchise as the firm prepares for an earlier-than-expected loss of exclusivity for the decongestant product
You may also be interested in...
Amid Growth, Reckitt To Launch Mucinex In Emerging Markets Ahead of EU
Emerging markets, the key driver for Reckitt Benckiser's nearly 20 percent net income growth, will be crucial in the firm's launch of Mucinex decongestants outside the U.S
Amid Growth, Reckitt To Launch Mucinex In Emerging Markets Ahead of EU
Emerging markets, the key driver for Reckitt Benckiser's nearly 20% net income growth, will be crucial in the firm's launch of Mucinex decongestants outside the U.S.
Amid Growth, Reckitt To Launch Mucinex In Emerging Markets Ahead of EU
Emerging markets, the key driver for Reckitt Benckiser's nearly 20% net income growth, will be crucial in the firm's launch of Mucinex decongestants outside the U.S.